logo
In Papua New Guinea's main hospital, thousands of women were left on the floor after giving birth

In Papua New Guinea's main hospital, thousands of women were left on the floor after giving birth

Less than 24 hours after giving birth, Christina Paulus is lying on the floor of a busy corridor in Papua New Guinea's main hospital.
Nurses hurry around with charts.
A cleaner wheels a mop bucket past her head.
Beside her on the linoleum floor, another woman's baby starts to cry.
As she rolls over to settle her newborn, Christina winces in pain.
She lost more than a litre of blood during the birth.
"The wounds are there. So when I'm sitting on the floor, it's uncomfortable," she says.
Around her, dozens of women and their babies are in the same predicament — sprawled on the floor in hallways and cramped in front of a reception desk.
Hallways cramped with women on the floor make delivering treatment difficult for staff.
(
ABC News: Marian Faa
)
Blocked sinks, broken walls and toilets that don't work properly
It's a scene that obstetrician Glen Mola is confronted with every morning when he walks into the maternity ward at the Port Moresby General Hospital (PMGH), where he's worked since 1987.
The once-charming wooden building — known fondly as the Susu Mamas clinic — was erected in 1958, when Papua New Guinea was under Australian colonial rule.
Staff say the maternity ward at Port Moresby General Hospital is struggling to cope.
(
ABC News: Marian Faa
)
"It's all PNG hardwood. It will never collapse," Dr Mola says, tapping the scuffed timber beneath his feet.
But he says the facility is in a state of severe neglect due to a lack of investment by hospital management.
"The walls are broken. The toilets are not working well. Some of the sinks are blocked. Lights are not working, taps don't work," Dr Mola says.
"There's no soap in the soap dispensers, no paper towels, so we dry our hands on our trousers. We need to do better.
"We're losing the ability to cope."
A key part of the problem is PNG's rapidly expanding population.
"The facilities we have here are sufficient for about 10,000 women a year. And we exceeded 10,000 back in the 90s," Dr Mola says.
While the country hasn't
It's clear that the capital, Port Moresby, is growing faster than many services can keep up with — Dr Mola's maternity ward included.
"People move into this city. I would say more than 1,000 a day, possibly," he estimates.
One of Papua New Guinea's most respected doctors, Glen Mola says he's disappointed to see services in decline.
(
ABC News: Marian Faa
)
Thousands of women treated on hospital floor
Frustrated with the conditions, Dr Mola and his team began documenting the state of care in the maternity ward last year.
In 2024, they found more than 7,000 women — about one in four — who visited the hospital to give birth received at least some of their care on the floor.
"Not being able to provide a bed for medical care is not just challenging from an ethical, social point. It's undignified, it's almost against rights, actually," Dr Mola says.
It also makes the work nearly impossible for staff.
"There's no way a midwife can sit down or kneel down on the floor beside you when there's blood and urine and [amniotic fluid] and faeces," he says.
"
Having a baby is a bit of a messy procedure — we need a bed with proper sort of hygiene and asepsis.
"
Photo shows
A man under anaesthetic lays on an operating table with his eyes closed, a breathing tube in his mouth
Many of Papua New Guinea's remote hospitals are struggling to survive, with no money, limited supplies, and patients in dire need of their help.
Over the Easter long weekend, two women and two babies died, at least partly because of insufficient capacity, according to Dr Mola.
He explains that a relaxed, comfortable environment is crucial for promoting positive birth outcomes.
"Birthing women require quietness, calmness, an ambience that makes them confident and feel as though everything's OK and they're being looked after," he says.
"Anxiety and fear are very anti-having-the-baby. If you have a lot of anxiety and fear, then women don't birth well."
Maternity ward upgrade ditched for hotel
As Dr Mola nears the end of his career, he is disappointed to see how things have gone downhill.
He's adamant it shouldn't be this way — and if everything had gone according to plan, he believes the clinic would be in a much better state today.
In 2022, the Japanese government committed $37 million in grant funding to revamp the Susu Mama wing with a new perinatal clinic that included more beds, a specialist ICU and laboratory.
Photo shows
Papua New Guinea Prime Minister James Marape points up with his right index finger.
Seventy projects outlined in a confidential PNG cabinet document include acquiring a luxury island in partnership with a Congolese rapper, exploring the potential for a world-class Formula 1 track, creating a "Silicon Valley style hub" for entrepreneurs and setting up a spy agency.
After more than 10 months of consultation with midwives, doctors, the Japanese embassy and developers, a comprehensive plan was presented to the hospital board.
But it was rejected because, according to Dr Mola, management believed it "did not fit with their vision for the future development of PMGH".
"The CEO looked at our plan and saw that it was going to be on this site and not on the site that he wants … so he can use this site for the hotel and shopping precinct," Dr Mola says.
He says the hospital's alternative plan is to build a new maternity wing in an eight-storey tower at a different site — which he argues is impractical.
Hospital management wants to upgrade smaller hospital
PMGH chief executive Dr Paki Molumi declined to answer questions posed by the ABC.
In a statement, National Capital District governor Powes Parkop said the Japanese grant was not refused, but PMGH management believed the money should go towards upgrading a smaller hospital on the city's outskirts.
Port Moresby General Hospital CEO Dr Paki Molumi declined to answer questions about conditions in the hospital.
(
ABC News: Marian Faa
)
"With more available land and growing infrastructure, [it] is ideally positioned to handle primary maternity and child health services for the city's rapidly growing population," Mr Parkop said.
He explained it was part of a larger plan to transition PMGH to a "level 6" hospital that will focus solely on specialised referrals and teaching, rather than serving direct admissions like maternity and child health cases.
Photo shows
Men in protective medical gowns pile coffins into a mass grave.
High burial costs are forcing families to abandon the bodies of loved ones at Papua New Guinea's public morgue, and many are ending up in mass graves.
In the longer-term, the provincial health authority wants to bolster smaller hospitals around the city to deal with primary care.
But Dr Mola says the maternity ward needs urgent relief.
PNG's Prime Minister James Marape has, in principle, thrown his weight behind the call.
Mr Marape summoned Health Minister Elias Kapavore to discuss issues at the hospital on Friday — a meeting Dr Mola described as "very positive", with the PM pledging funding or the cause.
"There is a need right away. We need to attend to it. So, we will attend to the immediate need as well as the long-term need," Mr Marape told ABC.
And with the average woman in PNG having at least four children in her life, Dr Mola, and the women he cares for, are depending on that promise being fulfilled.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

More than a dozen Aussie sunscreens fail to meet SPF claims on their labels, consumer group Choice finds in shock new report
More than a dozen Aussie sunscreens fail to meet SPF claims on their labels, consumer group Choice finds in shock new report

Sky News AU

time4 hours ago

  • Sky News AU

More than a dozen Aussie sunscreens fail to meet SPF claims on their labels, consumer group Choice finds in shock new report

More than a dozen favourite Australian sunscreens have failed to meet their SPF claims, according to a shock report by consumer group Choice. Twenty SPF 50 or 50+ products from different brands and retailers were subject to the test, which Choice said was conducted by experts in an accredited sunscreen lab. Sixteen of the 20 sunscreens under the microscope did not meet the SPF ratings stated on their labels, with only four living up to their claims, the analysis found. The worst performer, according to the report, was Ultra Violette's Lean Screen Mineral Mattifying Zinc Skinscreen which returned an SPF rating of four despite being labelled as 50+. Some Cancer Council products, including its SPF 50+ Ultra Sunscreen and Everyday Value Sunscreen SPF 50, tested at almost half their advertised ratings at 24 and 27, respectively. Woolworths' Sunscreen Everyday Tube SPF 50+ returned a rating of 27. Choice CEO Ashley de Silva said a follow up analysis was conducted for Ultra Violette's Lean Screen given the astonishing test result. "We were really shocked to see the results for Ultra Violette's Lean Screen SPF 50+ product, so much so that we actually decided to test a different batch at a completely different lab in Germany to confirm the results," he said in a statement. "Those tests found the product had an SPF of five - an almost identical result to our initial testing." A spokesperson for Ultra Violette said the company does not accept the results "as even remotely accurate". "Lean Screen contains 22.75 per cent zinc oxide, a level at which, when applied sufficiently, would render a testing result of SPF 4 scientifically impossible," a spokesperson said. Among the top performers included La Roche-Posay Anthelios Wet Skin Sunscreen SPF 50+ which tested as providing a higher protection rating of 72. Neutrogena's Ultra Sheer Body Lotion returned a slightly higher SPF of 56, over its printed label of 50, while the Cancer Council's Kid Sunscreen SPF 50+ tested at 52. Popular makeup brand Mecca Cosmetica's To Save Body Hydrating Sunscreen had an SPF of 51, according to the report. Choice has called on the Therapeutic Goods Administration to conduct its own compliance testing in the wake of the analysis, as it urges the ACCC to investigate any misleading SPF claims. "Currently, the TGA relies on reports provided by manufacturers to ensure the safety, quality and efficacy of sunscreen products," Mr de Silva said. "Unfortunately, these reports may not be providing the accurate information consumers need when choosing sunscreens for themselves and their families." However, Mr de Silva noted the consumer group's testing does not mean sunscreen is not effective. "While some specific sunscreens did not meet their claimed SPF, a sunscreen with an SPF of 30 or even 20 still offers a significant amount of sunscreen protection, and any sunscreen is better than none at all," he said. A TGA spokesperson confirmed to it is investigating the findings and will "take regularly action as required". The authority said it cannot comment on whether individual products may be subject to investigation, or compliance and enforcement activity due to privacy and legal restrictions. "The TGA acknowledges that there is variability in SPF testing results across laboratories, which is largely due to current reliance on human subject testing," a spokesperson said. "Limited inter-laboratory calibration may also lead to inconsistencies in methodologies and results. "While encouraging progress is being made internationally toward in-vitro sunscreen testing which would improve consistency of results, this will not eliminate the need for human subject testing, particularly for verifying water resistance claims." The TGA reiterated the importance of using sunscreen in addition to other sun safety measures such as wearing a wide-brimmed hat, protective clothing and sunglasses. "We note that a number of the products Choice tested provided results in the range of SPF 30," the regulator said. "It is important to note that SPFs in the range of 30 to 59 provide 'High protection', while a SPF of 60 or higher (SPF 50+) provides 'Very high' protection. "Therefore, products with an SPF of 30 are effective to use. "Consumers are also advised that, irrespective of the SPF rating, sunscreens should be applied liberally and reapplied frequently." A spokesperson for the ACCC said it is considering the issues raised in Choice's report in accordance with its Compliance and Enforcement Policy. "The ACCC will engage closely with the Therapeutic Goods Administration in considering the allegations," a spokesperson said in a statement to "In addition to obligations under therapeutic goods legislation, businesses also have obligations under the Australian Consumer Law, including an obligation not to make false or misleading representations." has contacted the Cancer Council and Ultra Violette for further comment.

Beleaguered Monash IVF CEO Michael Knapp resigns days after second embryo mix-up plagues company
Beleaguered Monash IVF CEO Michael Knapp resigns days after second embryo mix-up plagues company

Sky News AU

time6 hours ago

  • Sky News AU

Beleaguered Monash IVF CEO Michael Knapp resigns days after second embryo mix-up plagues company

CEO of Monash IVF Michael Knapp has resigned two days after the fertility clinic mistakenly transferred the wrong embryo into a patient, the second incident for the company in months. On June 5 the Clayton fertility clinic, in Melbourne's south-east, admitted to wrongly giving a patient her biological embryo, instead of her partners as planned. "Monash IVF has extended its sincere apologies to the affected couple, and we continue to support them," the company said in a statement on the ASX on Tuesday. The company said it was conducting an internal investigation into the incident, and comes just months after it revealed that one of its patients had given birth to a stranger's child in a shocking embryo mix-up that made headlines across the country in April. In a statement to the ASX on Thursday, Monash IVF said it had accepted the resignation of current Chief Executive Officer and Managing Director Michael Knapp and that the board 'acknowledges and respects his decision'. 'Since his appointment in 2019, Michael has led the organisation through a period of significant growth and transformation, and we thank him for his years of dedicated service,' the statement read. Mr Knapp has occupied the role since 2019 after being appointed interim CEO in 2018 and was formerly Monash IVF Group's chief financial officer and company secretary. The company said its current Chief Financial Officer and Company Secretary, Malik Jainudeen, would be appointed as his replacement. 'Monash IVF Group Chief Financial Officer and Company Secretary, Malik Jainudeen has been appointed as Acting Chief Executive Officer," the statement said. Mr Knapp's departure comes a day before the Australian health ministers meeting in Melbourne, with IVF regulation set to dominate discussion after the damaging mishap. This is a developing story. More to come.

The hidden menace on the rise in Australia's favourite winter holiday destinations
The hidden menace on the rise in Australia's favourite winter holiday destinations

Sydney Morning Herald

time11 hours ago

  • Sydney Morning Herald

The hidden menace on the rise in Australia's favourite winter holiday destinations

Of the 13,343 dengue cases reported in Australian between 2012 and 2022, 94 per cent were contracted overseas, mostly from Thailand and Indonesia, a Journal of Travel Medicine study found. One paper estimated six out of every 1000 travellers to high-risk areas catch dengue per month. Several variants are circulating at once, driving the current outbreaks. Climate change has also expanded mosquito habitats, accelerated breeding cycles and shortened the time the virus needs to replicate within its insect hosts, Dr Gregor Devine at the World Mosquito Program said. Warmer temperatures may have also weakened a key weapon dispatched against dengue-carrying mosquitoes across Asia and the Pacific, including Australia. When mosquitoes are infected with a type of bacteria called Wolbachia, their ability to transmit viruses is vastly reduced. Scientists have bred Wolbachia-infected mosquitoes into local populations around Cairns and Townsville, for example, and almost eradicated local cases of dengue. (A case reported in Cairns in May, however, marked the first locally acquired dengue infection since 2018). The World Mosquito Program rolled out the technique in two regions of Bali last year and expects it could prevent half a million dengue cases over 15 years. Similar programs are planned or underway in other badly hit countries including Kiribati and Timor-Leste. The bacteria, however, are sensitive to heat and start to die off within mosquito larva when temperatures surpass 30 degrees, mosquito expert Dr Perran Stott-Ross from the University of Melbourne said. That could contribute to more dengue cases as hot days and heat waves become more frequent. 'There's a pretty clear link between temperature and Wolbachia loss,' Stott-Ross said. 'We know when Cairns had its hottest day on record several years ago that the Wolbachia took a bit of a hit.' Loading There is another proposed dengue-busting proposal on the table, but Stott-Ross is cautious about the idea while the Wolbachia approach remains effective. UK company Oxitec and the CSIRO have applied to release genetically modified male mosquitoes in Queensland to slash populations of invasive, disease-carrying Aedes aegypti mosquitoes. Oxitec's mosquitos pass on a DNA tweak which kills female larvae. But Stott-Ross is concerned that could undermine the Wolbachia method if there's a crash in mosquito numbers and then mosquitoes without the bacteria re-populate. 'I think it's a really useful technology. I just don't think there's a need for it in Australia at the moment,' he said. 'We've already got something which seems to be working quite well which is the Wolbachia, and it's already been released pretty much everywhere in Queensland where dengue would be a concern.' Oxitec said in a statement that having other tools to control mosquitoes 'can only be a good thing for local authorities' given the Wolbachia approach hadn't fully eliminated dengue. Stott-Ross is researching more heat-tolerant strains of Wolbachia and how mosquitoes could spread under climate change.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store